FranΓ§aisπ See the interactive version (live chart) β
| Metric | Value | What it means |
|---|---|---|
| P/E (price / earnings) | 58.8 | The higher, the more growth the market expects. |
| Forward P/E | 18.0 | On next year's expected earnings. Lower than current P/E = rising earnings. |
| PEG (P/E Γ· growth) | β | Below 1 = cheap given growth; above 2 = expensive. |
| Net margin | 3% | Share of revenue that ends up as profit. |
| Revenue growth | 7% | Pace of revenue growth. |
| Price-to-book | 10.4 | Price relative to book value. |
| Market cap | $17.0 B | Total market value of the company. |
| Dividend yield | 1.25% | Annual dividend ~$0.50/share relative to price. |
| Year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2022 | $1.7 B | $137 M | 8% |
| 2023 | $2.1 B | $61 M | 3% |
| 2024 | $2.5 B | $230 M | 9% |
| 2025 | $3.1 B | $214 M | 7% |
π Open the interactive Ryan Specialty page (charts, live news) β
Ryan Specialty has a P/E of 58.8 (forward P/E 18.0) and a PEG of β. A PEG below 1 is rather cheap given growth, above 2 is expensive. Verdict: valuation to review.
Ryan Specialty's net margin is about 3% β the share of revenue that ends up as net profit.
Latest known revenue: $3.1 B for net income of $214 M. The year-by-year breakdown is in the income statement above.
Ryan Specialty (RYAN) has a market cap of about $17.0 B.
Yes: Ryan Specialty pays about $0.50/share per year, i.e. roughly a 1.25% yield at the current price.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Data: Yahoo Finance, recomputed by JPI Invest. A stock can be Β« cheap Β» for a bad reason.